BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 18194240)

  • 1. Sirolimus and regression of Kaposi's sarcoma in immunosuppressed transplant patient.
    Pranteda G; Feliziani G; Grimaldi M; Paleologo G; Pranteda G; Melotti F; Camplone G
    J Eur Acad Dermatol Venereol; 2008 Aug; 22(8):1022-3. PubMed ID: 18194240
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel immunosuppressive agent, sirolimus, in the treatment of Kaposi's sarcoma in a renal transplant recipient.
    Yilmaz R; Akoglu H; Kirkpantur A; Kilickap S; Arici M; Altun B; Aki T; Erdem Y; Yasavul U; Turgan C
    Ren Fail; 2007; 29(1):103-5. PubMed ID: 17365918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sirolimus for Kaposi's sarcoma.
    Wasywich CA; Croxson MC; van Doornum GJ; Coverdale HA; Ruygrok PN
    J Heart Lung Transplant; 2006 Jun; 25(6):726-9. PubMed ID: 16730579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of post-transplant Kaposi's sarcoma using sirolimus.
    Kolhe N; Mamode N; Van der Walt J; Pattison J
    Int J Clin Pract; 2006 Nov; 60(11):1509-12. PubMed ID: 16787440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirolimus for Kaposi's sarcoma in renal-transplant recipients.
    Stallone G; Schena A; Infante B; Di Paolo S; Loverre A; Maggio G; Ranieri E; Gesualdo L; Schena FP; Grandaliano G
    N Engl J Med; 2005 Mar; 352(13):1317-23. PubMed ID: 15800227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kaposi's sarcoma in the early post-transplant period in a kidney transplant recipient.
    Ercan Z; Demir ME; Merhametsiz O; Yayar O; Ulas T; Ayli MD
    Nefrologia; 2013 Nov; 33(6):861-2. PubMed ID: 24241380
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecularly targeted therapy for Kaposi's sarcoma in a kidney transplant patient: case report, "what worked and what did not".
    Volkow P; Zinser JW; Correa-Rotter R
    BMC Nephrol; 2007 Mar; 8():6. PubMed ID: 17386117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of a child having generalized Kaposi's sarcoma after living donor liver transplantation with conversion to sirolimus.
    Yuksekkaya HA; Arikan C; Yazici A; Baran M; Aydogdu S; Kilic M
    Pediatr Transplant; 2009 May; 13(3):375-8. PubMed ID: 18452496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kaposi's sarcoma after renal transplantation.
    Kanitakis J
    N Engl J Med; 2005 Aug; 353(8):846-7; author reply 846-7. PubMed ID: 16120869
    [No Abstract]   [Full Text] [Related]  

  • 10. Regression of Kaposi's sarcoma in renal graft recipients after conversion to sirolimus treatment.
    Zmonarski SC; Boratyńska M; Rabczyński J; Kazimierczak K; Klinger M
    Transplant Proc; 2005 Mar; 37(2):964-6. PubMed ID: 15848592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapamycin for Kaposi's sarcoma and graft-versus-host disease in bone marrow transplant recipient.
    Marco de F; Infante B; Giovanni S; Gesualdo L
    Transplantation; 2010 Mar; 89(5):633-4. PubMed ID: 20216371
    [No Abstract]   [Full Text] [Related]  

  • 12. No effect of sirolimus for kaposi sarcoma in a renal transplant recipient.
    Descoeudres B; Giannini O; Graf T; Steiger J; Mayr M
    Transplantation; 2006 May; 81(10):1472-4. PubMed ID: 16732189
    [No Abstract]   [Full Text] [Related]  

  • 13. Classic Mediterranean Kaposi's sarcoma regression with sirolimus treatment.
    Guenova E; Metzler G; Hoetzenecker W; Berneburg M; Rocken M
    Arch Dermatol; 2008 May; 144(5):692-3. PubMed ID: 18490609
    [No Abstract]   [Full Text] [Related]  

  • 14. Unusual Kaposi's sarcoma in a renal transplant recipient.
    Costa Ferreira P; Miguel Pereira J; Oliveira I; Pinho C; Cardoso A; Reis J; Amarante J
    Nephrol Dial Transplant; 2005 Dec; 20(12):2830-1. PubMed ID: 16204279
    [No Abstract]   [Full Text] [Related]  

  • 15. Sirolimus for visceral and cutaneous Kaposi's sarcoma in a renal-transplant recipient.
    Gheith O; Bakr A; Wafa E; Fouda A; El Agroudy A; Refaie A; Donia A; Sabry A; Sobh M; Shokeir A; Ghoneim M
    Clin Exp Nephrol; 2007 Sep; 11(3):251-254. PubMed ID: 17891357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive drugs and the risk of cancer after organ transplantation.
    Dantal J; Soulillou JP
    N Engl J Med; 2005 Mar; 352(13):1371-3. PubMed ID: 15800234
    [No Abstract]   [Full Text] [Related]  

  • 17. Complete regression of visceral Kaposi's sarcoma after conversion to sirolimus.
    Mohsin N; Budruddin M; Pakkyara A; Darweesh A; Nayyer M; Amitabh J; Daar AS
    Exp Clin Transplant; 2005 Dec; 3(2):366-9. PubMed ID: 16417445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirolimus for the treatment of Kaposi sarcoma after renal transplantation: a series of 10 cases.
    Yaich S; Charfeddine K; Zaghdane S; El Aoud N; Jarraya F; Kharrat M; Hachicha J
    Transplant Proc; 2012 Nov; 44(9):2824-6. PubMed ID: 23146533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iatrogenic Kaposi's sarcoma in a patient with pemphigus vulgaris.
    Serdaroglu S; Antonov M; Demirkesen C; Tuzun Y
    Clin Exp Dermatol; 2009 Oct; 34(7):839-40. PubMed ID: 19747341
    [No Abstract]   [Full Text] [Related]  

  • 20. Sirolimus (rapamycin): from the soil of Easter Island to a bright future.
    Paghdal KV; Schwartz RA
    J Am Acad Dermatol; 2007 Dec; 57(6):1046-50. PubMed ID: 17583372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.